מיפג'ין

Nchi: Israeli

Lugha: Kiebrania

Chanzo: Ministry of Health

Viambatanisho vya kazi:

MIFEPRISTONE

Inapatikana kutoka:

A. LAPIDOT PHARMACEUTICALS, LTD

ATC kanuni:

G03XB01

Dawa fomu:

טבליה

Tungo:

MIFEPRISTONE 200 MG

Njia ya uendeshaji:

פומי

Dawa ya aina:

מרשם נדרש

Viwandani na:

EXELGYNE LABORATORIES, FRANCE

Kundi la matibabu:

MIFEPRISTONE

Eneo la matibabu:

MIFEPRISTONE

Matibabu dalili:

Medical alternative to uterine suction for termination of intra-utrerine Pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after Mifegyne intake. Under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.

Idhini ya tarehe:

2014-07-31